Baltimore, MD, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Weight regain after initial weight loss is a recogn

MED's revenue is stabilizing as coach productivity and client retention improve, though a shrinking

Baltimore, MD, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Weight comes back after weight loss when the condit

Baltimore, MD, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The signs of poor metabolic health can be difficult

Trilivy™ is designed to address the challenges of metabolic dysfunction Clients on Trilivy's Reset 5

MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater eff

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Meta

MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing G

Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflecte

Great Lakes Advisors LLC purchased a new position in shares of Medifast Inc (NYSE: MED) in the undef

MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp

MED's improving coach productivity and client retention point to stabilization, but a shrinking coac

Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach bas

Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations supp

Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue

Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown ag

MED tops Q2 earnings expectations despite lower sales, as rising coach productivity helps offset pre

Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript

Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market ses

Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees

Medifast (NYSE:MED) reported quarterly losses of $(0.28) per share which beat the analyst consensus

The leading health and wellness company unveils an evolutionary transformation from weight loss to o

Medifast (NYSE:MED) affirms FY2026 GAAP EPS guidance from $(2.75)-$(1.55) to $(2.75)-$(1.55) vs $(1.

Medifast (NYSE:MED) is looking for Q2 GAAP EPS of $(1.00)-$(0.50) vs $(0.43) analyst estimate. sees

Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus

Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed,

 Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is a

Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lower

Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide conti

Medifast (NYSE:MED) reported quarterly earnings of $0.22 per share which beat the analyst consensus

Medifast (NYSE:MED) Q3 expected to be more than $(0.60) vs $(0.30) Est. sees Q3 sales of $70.000 mi

Medifast (NYSE:MED) Q2 expected to be more than $(0.55) vs $(0.08) Est. sees Q2 sales of $85.000 mi

Medifast (NYSE:MED) reported quarterly losses of $(0.07) per share which beat the analyst consensus

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers t

All three major U.S. indices are red in Wednesday's midday trading as investors weighed Presiden

Medifast (NYSE:MED) Q1 expected to be more than $(0.50) vs $(0.19) Est. sees Q1 sales of $100.000 m